Physician profile
Melody Blum
NPI 1083178347
$1,147.87
in general payments reported to CMS, 2019-2025
20 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $69.22 · 2024: $591 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.88 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $319.48 | 2024-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $124.75 | 2023-2025 | |
| Sonex Health, INC. | $98.76 | 2025 | Sx-One Microknife |
| Merck Sharp & Dohme LLC | $91.90 | 2024-2025 | Pifeltro, Capvaxive, Delstrigo |
| Glaxosmithkline, LLC. | $88.92 | 2023-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $51.87 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $50.28 | 2024-2025 | General - Pain Management |
| Corcept Therapeutics | $46.07 | 2025 | Korlym |
| Pfizer INC. | $45.35 | 2024 | |
| Viiv Healthcare Company | $34.19 | 2024 | Apretude, Rukobia |
| Insmed, INC. | $33.00 | 2025 | Arikayce |
| Xeris Pharmaceuticals, INC. | $22.78 | 2025 | Keveyis |
| Hologic Sales and Service, LLC | $22.37 | 2025 | Thinprep 2000 Processor, Aptima |
| Teva Pharmaceuticals USA, INC. | $21.06 | 2025 | Ajovy |
| Csl Behring | $19.46 | 2024 | Kcentra, Haegarda |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $19.39 | 2024 | Idacio |
| Astrazeneca Pharmaceuticals LP | $16.42 | 2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $14.79 | 2023 | |
| Lilly USA, LLC | $13.54 | 2025 | Mounjaro, Zepbound |
| Qiagen, LLC | $13.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.